tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adicet Bio Implements Reverse Stock Split to Maintain Listing
PremiumCompany AnnouncementsAdicet Bio Implements Reverse Stock Split to Maintain Listing
2M ago
Adicet Bio Shareholders Approve Flexible Reverse Stock Split
Premium
Company Announcements
Adicet Bio Shareholders Approve Flexible Reverse Stock Split
2M ago
Adicet Bio’s Promising Pipeline and Strategic Focus Drive Buy Rating
Premium
Ratings
Adicet Bio’s Promising Pipeline and Strategic Focus Drive Buy Rating
4M ago
Adicet Bio doses first patient in ADI-001 trial
PremiumThe FlyAdicet Bio doses first patient in ADI-001 trial
5M ago
Adicet Bio’s Promising Off-the-Shelf Cell Therapy Garners Buy Rating Due to Positive Clinical Outcomes and Strong Market Position
Premium
Ratings
Adicet Bio’s Promising Off-the-Shelf Cell Therapy Garners Buy Rating Due to Positive Clinical Outcomes and Strong Market Position
5M ago
Adicet Bio price target raised to $8 from $7 at Guggenheim
Premium
The Fly
Adicet Bio price target raised to $8 from $7 at Guggenheim
5M ago
Adicet Bio’s ADI-001 shows positive preliminary Phase 1 results in LN and SLE
PremiumThe FlyAdicet Bio’s ADI-001 shows positive preliminary Phase 1 results in LN and SLE
5M ago
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
Premium
Ratings
Adicet Bio’s Promising CAR γδ T Cell Therapy: A Buy Rating Amidst Anticipated Breakthroughs in Lupus Treatment
5M ago
Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
Premium
Ratings
Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100